One of the most widespread health concerns in the United States revolves around chronic or long-term pain. Unlike temporary discomfort caused by short illnesses or minor injuries, chronic pain often reshapes how people work, sleep, exercise, and interact with daily life.
According to the CDC’s November 2024 National Health Interview Survey data, 24.3% of U.S. adults experienced chronic pain in 2023, with 8.5% experiencing high-impact chronic pain that frequently limited their life or work activities.
However, despite there being many medical treatments for long-term and chronic pain, many people find themselves dissatisfied and turning to alternatives. In this article, we’ll explore the viability of cannabis as a remedy for long-term pain. Let’s dig in.
What Kind of Injuries Tend To Cause Long-Term Pain?
Some injuries heal cleanly within weeks or months. Others can leave behind pain that lingers for years because nerves, joints, connective tissue, or the brain’s pain-processing systems were affected. Generally, the most common sources of chronic pain result from back and spinal injuries or issues related to joints and nerves.
Car accidents tend to be a good example of a common injury source that can lead to long-term pain. Car crashes happen every day in America at varying levels of severity. Recently, in Little Rock, Arkansas, one individual died while another was injured after a crash. In such a case, hiring a Little Rock auto accident lawyer is often the first step that’s taken.
After all, as Keith Law Group notes, car accidents can lead to even hundreds of thousands of dollars in debt. The earlier people get help managing their situation, the better. However, what about the long-term consequences? For many car crash victims, their injuries never fully recover.
Take whiplash injuries, which are incredibly common in car crashes. One study found that peripheral nerve pathology is present in a proportion of whiplash patients and is strongly linked to worse long-term outcomes. A subset of the patients also showed evidence of peripheral nerve involvement, such as sensory deficits, abnormal nerve conduction, and other neuropathic pain features.
Conventional treatments for neuropathic pain tend to involve antidepressants, anticonvulsants, or topical nerve medications. While these can help, the results vary widely. This is where cannabis as a treatment option is showing particular promise.
The Case for Cannabis in Treating Long-Term Neuropathic Pain
Neuropathic pain can be difficult to live with because it often behaves differently from ordinary pain. Instead of soreness caused by inflammation or injury alone, patients may experience burning sensations, electric-shock feelings, hypersensitivity, or persistent tingling. Cannabis may help by affecting several different systems tied to pain perception, inflammation, and nervous system activity.
One review found that 15 out of 22 studies showed significant neuropathic pain reduction after the use of cannabis-based medicines. The other 7 studies found no significant benefit compared to placebo but still showed minor improvements in secondary outcomes.
A key factor behind its effectiveness comes from reducing overactive nerve signaling. Cannabinoids such as THC and CBD interact with the body’s endocannabinoid system, which plays a role in regulating pain transmission. Some researchers believe this interaction may help calm excessive nerve firing that contributes to neuropathic pain symptoms.
Likewise, it also has the potential to decrease central sensitization. This is where the nervous system becomes overly reactive. In these cases, even a light touch or minor stimulation can feel painful.
Cannabis may help dampen this heightened sensitivity in certain individuals, making everyday sensations feel less overwhelming. Patients sometimes report reduced sensitivity to clothing, pressure, or temperature changes.
Cannabis Research and Federal Policy Are Entering a Different Stage
Public conversations surrounding cannabis have shifted significantly in recent years. Patients dealing with long-term accident injuries are becoming part of broader conversations as researchers investigate cannabis-based therapies more seriously.
The legal landscape reflects this as well. Recently, the U.S. Department of Justice reclassified cannabis from a Schedule I narcotic (same category as heroin) to a Schedule III drug (similar to Tylenol with codeine). This came after President Trump directed the move to expand access and enable more research into cannabis’ medical uses.
According to Morgan Fox of the National Organization for the Reform of Marijuana Laws, two-thirds of Americans support full legalization of cannabis. He notes that the real solution would be to deschedule cannabis at the federal level instead of just moving it to Schedule III.
That said, the change is better than nothing. For researchers, it creates more opportunities to study dosage standards, long-term neurological effects, treatment safety, and effectiveness with fewer federal barriers. For patients, it may gradually increase access to medically supervised discussions about cannabis-based treatments rather than relying entirely on anecdotal advice found online.
Sure, some researchers continue to emphasize that cannabis is not universally effective for every chronic pain patient. However, considering that conventional medicine has had a hit-or-miss level of success for many neuropathic patients, cannabis as a potential solution shouldn’t be taken lightly.
Even if it can’t fully cure, it can still offer comfort. This is still massive because, for many people, the larger objective is not the complete elimination of discomfort. Instead, the goal is to find enough relief and stability to participate more fully in everyday life again.
Frequently Asked Questions
1. Is medical cannabis commonly used for chronic pain management?
Yes, medical cannabis has become increasingly common among chronic pain patients, especially those dealing with nerve-related pain. Many people use it alongside physical therapy or other treatments to help with sleep, discomfort, and daily functioning, particularly when traditional pain medications create unwanted side effects or dependency concerns.
2. Does cannabis affect pain differently than opioids?
Cannabis and opioids interact with the body differently. Opioids mainly block pain signals, while cannabis affects systems connected to pain perception, inflammation, mood, and relaxation. Some patients report that cannabis helps reduce pain intensity without the heavy sedation or dependency risks often associated with long-term opioid use.
3. Will cannabis reclassification increase chronic pain research in the future?
Reclassification is expected to make cannabis research easier in several ways. Researchers may face fewer federal barriers when studying medical uses, dosage standards, and long-term effects. This could lead to clearer evidence regarding how cannabis-based treatments perform for chronic pain, nerve injuries, and post-accident recovery.
Key Numbers and Figures at a Glance
| Percentage of U.S. adults who experienced chronic pain | 24.3% |
| Percentage of U.S. adults with high-impact chronic pain limiting work or life activities | 8.5% |
| Portion of the population that supports full cannabis legalization | Two-thirds of Americans |
| Recent legislative changes on Cannabis | Reclassification from Schedule I to Schedule III |
Chronic neuropathic pain has occupied an uncomfortable space in medicine. It is common enough to affect millions of Americans, yet unpredictable enough that many patients spend years cycling through medications, therapies, and specialist visits without finding meaningful consistency. This is one of the reasons why interest in cannabis has expanded beyond cultural debates and into clinical discussions surrounding pain management itself.
Sure, cannabis research still has significant gaps, and there are valid concerns surrounding standardization, long-term effects, and patient-specific outcomes. At the same time, growing cannabis research reflects recognition that conventional chronic pain treatments do not work consistently for all patients.
